New hope for kidney patients: diabetes drug may fix anemia
NCT ID NCT07334145
First seen Jan 12, 2026 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests whether SGLT2 inhibitors, a type of diabetes medicine, can improve anemia in people with chronic kidney disease (CKD). Anemia is common in CKD and often requires iron or other injections, which have side effects. The trial will measure changes in hemoglobin levels in 60 adults with mild-to-moderate CKD and stable anemia over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA IN CKD PATIENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sohag University Hospital
Sohag, Sohag University, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.